NDC 50102-130-01 - CHATEAL
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50102-130
- Requested NDC
- 50102-130-01
- Package NDCs from labels
- 50102-130-00, 50102-130-01, 50102-130-48, 50102-130-10, 50102-130-03
- Manufacturer
- Afaxys Pharma, LLC | Mylan Laboratories Limited
- Effective date
- 2021-01-27
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CHATEAL - Afaxys Pharma, LLC | Mylan Laboratories Limited | Afaxys Pharma, LLC | Mylan Laboratories Limited | 2021-01-27 | HUMAN PRESCRIPTION DRUG LABEL |
| Chateal® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg) | RPK Pharmaceuticals, Inc. | 2020-12-15 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 50102-130-03 | 2023-02-24 | Chateal® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg) |
| 50102-130-48 | 2023-02-24 | Chateal® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg) |
| 50102-130-03 | 2023-01-30 | Chateal® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg) |
| 50102-130-48 | 2023-01-30 | Chateal® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg) |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50102-130-00 | EA - Each | 50102-130 | dcb62401-8949-464e-ab16-85f9c6f4c40d | 1 | 2022-06-06 |
| 50102-130-01 | EA - Each | 50102-130 | b8bb767c-e280-45f7-828d-4a8aaae9c21c | 1 | 2013-02-13 |
| 50102-130-03 | EA - Each | 50102-130 | 61c25f8e-2546-4292-98d9-3172853ce2f1 | 1 | 2017-09-11 |
| 50102-130-10 | EA - Each | 50102-130 | 4a3fd139-d25f-40ed-939c-42f8b7d58d0e | 1 | 2017-09-11 |
| 50102-130-48 | EA - Each | 50102-130 | 1a4669e5-b979-4386-ba8b-04d4f4b7e28e | 1 | 2013-02-13 |
| 50102-130-90 | EA - Each | 50102-130 | 3536e405-15d6-482b-949b-31b922af726b | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levonorgestrel | LEVONORGESTREL | Ohm Laboratories Inc. | 5c509934-8c11-4d7f-8506-5971c37cfc22 | 2024-09-06 | Warnings | 5W7SIA7YZW |
| Etonogestrel and Ethinyl Estradiol Vaginal Ring | ETONOGESTREL AND ETHINYL ESTRADIOL VAGINAL RING | Northstar Rx LLC | 1488f5ae-3b34-fcd7-6049-215929b1d324 | 2024-06-24 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| EnilloRing | ETONOGESTREL AND ETHINYL ESTRADIOL VAGINAL | Xiromed, LLC | 85a126f6-d3e0-9e12-73f9-6176ba36f58b | 2024-06-24 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| My Way | LEVONORGESTREL | NuCare Pharmaceuticals,Inc. | 6598a875-8be8-0928-e053-2a91aa0a064d | 2024-06-06 | Warnings | 5W7SIA7YZW |
| NUVARING | ETONOGESTREL AND ETHINYL ESTRADIOL | A-S Medication Solutions | e14bc197-dd22-4e6e-8aa1-d6cf2242fe0f | 2024-03-10 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| Jinteli | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL | Teva Pharmaceuticals USA, Inc. | d667ca75-1a17-43fc-9077-f25ce0908f8d | 2024-02-27 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| XULANE | NORELGESTROMIN AND ETHINYL ESTRADIOL | A-S Medication Solutions | adcf17ef-e60b-48a4-9478-3998dab2bbbd | 2024-02-27 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL | Mylan Pharmaceuticals Inc. | 3108a9bc-3378-459d-8f6b-bd5eff2ad657 | 2024-01-15 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL | Mylan Pharmaceuticals Inc. | 89948751-bd6e-4e9c-b87c-8782706c1097 | 2024-01-15 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| ZAFEMY | NORELGESTROMIN AND ETHINYL ESTRADIOL | Bryant Ranch Prepack | 77230a20-4269-4abf-ae2a-ac5ccafef565 | 2024-01-05 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| Etonogestrel/Ethinyl Estradiol | ETONOGESTREL AND ETHINYL ESTRADIOL | A-S Medication Solutions | fcf9da2a-bb91-4697-bfaa-c9d58855e275 | 2023-11-22 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| Aurovela 1.5/30 | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL | Aurobindo Pharma Limited | b146e49c-a0fc-4f3d-9ad6-99e8257fa139 | 2023-11-21 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| PostDay One-Step | LEVONORGESTREL | Rapha Pharmaceuticals, Inc. | 6f7f5697-acb6-ea95-e053-2991aa0ae7c7 | 2023-11-21 | Warnings | 5W7SIA7YZW |
| Aurovela 1/20 | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL | Aurobindo Pharma Limited | 6765becf-7b51-4f33-ac13-70fcd01decf7 | 2023-11-21 | Warnings, Adverse reactions | 423D2T571U |
| Plan B One-Step | LEVONORGESTREL | A-S Medication Solutions | fcc7ba8e-ad54-4efe-87e4-5eb0fbf4f064 | 2023-10-24 | Warnings | 5W7SIA7YZW |
| Levonorgestrel | LEVONORGESTREL | Xiromed LLC | 626a2333-ff56-ef28-a287-b33bacc0302a | 2023-09-05 | Warnings | 5W7SIA7YZW |
| Anubis Barcelona | GLYCERIN, SORBITOL, ALOE BARBADENSIS LEAF JUICE | ANUBIS COSMETICS SL | eb651769-4d98-2b3b-e053-2a95a90a36b0 | 2023-09-01 | Warnings | H3R47K3TBD |
| Anubis Barcelona Total Hydrating | BETAINE, GLYCERIN, POLYSORBATE 20 | ANUBIS COSMETICS SL | eaefe3b9-9064-18b1-e053-2a95a90a5765 | 2023-09-01 | Warnings | H3R47K3TBD |
| Anubis Barcelona New Even | LACTIC ACID, CITRIC ACID, GLYCOLIC ACID | ANUBIS COSMETICS SL | eaeeb6e0-5322-20c4-e053-2995a90a9fd9 | 2023-09-01 | Warnings | H3R47K3TBD |
| LILETTA | LEVONORGESTREL | Allergan, Inc. | aaf0eb2a-f88a-4f26-a445-0fd30176c326 | 2023-06-29 | Warnings, Adverse reactions | 5W7SIA7YZW |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.